Metformin 500 mg & Gliclazide 80 mg (Sustained Release)

Get a Price/Quote

MOQ : 15-30 Boxes

Metformin 500 mg & Gliclazide 80 mg (Sustained Release) Specification

Drug Type
Specific Drug

Ingredients
Glimepride 2 mg + Pioglitazone 30 mg (SR)

Physical Form
Tablets

Function
Other

Recommended For
Type 2 Diabetes Mellitus

Metformin 500 mg & Gliclazide 80 mg (Sustained Release) Trade Information

Minimum Order Quantity
15-30 Boxes

Payment Terms
Western Union, Paypal, Cash in Advance (CID), Cheque, Cash Advance (CA)

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
Blister Pack, 2*5*10

Main Domestic Market
All India

Certifications
WHO-GMP

About Metformin 500 mg & Gliclazide 80 mg (Sustained Release)

Metformin 500 mg & Gliclazide 80 mg (Sustained Release) tablets are specifically formulated to manage Type 2 Diabetes Mellitus effectively. This combination of medications works synergistically to regulate blood sugar levels in adults and elderly patients. Metformin, a cornerstone treatment for diabetes, decreases glucose production in the liver and improves insulin sensitivity. Gliclazide, as a sustained-release agent, enhances insulin secretion for extended glycemic control. Designed in tablet form for easy oral administration, these medications prioritize convenience and efficacy. They are particularly suitable for individuals requiring tailored management solutions for their diabetes, ensuring improved metabolic function and sustained health outcomes.

FAQs of Metformin 500 mg & Gliclazide 80 mg (Sustained Release):

Q: What is Metformin 500 mg & Gliclazide 80 mg (Sustained Release) recommended for?

A: It is recommended for treating Type 2 Diabetes Mellitus by effectively regulating blood sugar levels.

Q: Who can use these tablets?

A: These tablets are suitable for adults and elderly individuals diagnosed with Type 2 Diabetes Mellitus.

Q: How does the combination of Metformin and Gliclazide work?

A: Metformin reduces glucose production and improves insulin sensitivity, while Gliclazide stimulates insulin secretion for prolonged blood sugar control.